| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |